Thursday, 16 August 2018

FDA approves Teva's generic of Mylan's EpiPen

The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)